Our Leaders

Bruce Teplitzky is Executive Vice President of Strategic Drug Development for PRA. In this position, Mr. Teplitzky focuses on designing strategies to maximize the drug development life cycle with PRA's client base. At PRA, he is responsible for the Strategic Patient Access Division. Prior to his current position, Mr. Teplitzky has held a variety of positions within PRA's Operations and Business Development organization.

A 25-year veteran of the drug development industry, Mr. Teplitzky joined PRA in 1996 as Vice President of Operations and Regional Director, which included overseeing the company's Charlottesville Trials Management Center. He possesses an extensive background in clinical drug develop and has overseen an extensive number of global programs which have lead to product commercialization.

Mr. Teplitzky earned his M.M.Sc. at the Emory University School of Medicine. He received his B.S. from Emory University in Biologic Sciences.